Literature DB >> 23897793

Risk of cardiac rupture after acute myocardial infarction is related to a risk of hemorrhage.

Geng Qian1, Hong-bin Liu, Jin-wen Wang, Chen Wu, Yun-dai Chen.   

Abstract

Although cardiac rupture (CR) is a fatal mechanical complication of acute myocardial infarction (AMI), to date no predictive model for CR has been described. CR has common pathological characteristics with major bleeding. We aimed to investigate the relationship between the risk factors of major bleeding and CR. A total of 10202 consecutive AMI patients were recruited, and mechanical complications occurred in 72 patients. AMI patients without CR were chosen as control group. Clinical characteristics including bleeding-related factors were compared between the groups. The incidences of free wall rupture (FWR), ventricular septal rupture (VSR), and papillary muscle rupture (PMR) were 0.39%, 0.21%, and 0.09%, respectively, and the hospital mortalities were 92.5%, 45.5%, and 10.0%, respectively. Female proportion and average age were significantly higher in the groups of FWR and VSR than in the control group (P<0.01); higher white blood cell count and lower hemoglobin were found in all CR groups (P<0.01). Compared to the control group, patients with CR were more likely to receive an administration of thrombolysis [26.39% vs. 13.19%, P<0.05], and were less likely to be treated with primary percutaneous coronary intervention (PCI) [41.67% vs. 81.60%, P<0.05]. The major bleeding scores (integer scores) of FWR, VSR, and PMR were (17.70±7.24), (21.91±8.33), and (18.60±7.88), respectively, and were significantly higher than that of the control group (11.72±7.71) (P<0.05). A regression analysis identified age, increased heart rate, anemia, higher white blood cell count, and thrombolysis as independent risk factors of CR, most of which were major bleeding-related factors. The patients with CR have a significantly higher risk of hemorrhage compared to the group without CR. Risk of CR after AMI is related to the risk of hemorrhage.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23897793      PMCID: PMC3735974          DOI: 10.1631/jzus.B1200306

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  24 in total

1.  Increased pericardial fluid level of matrix metalloproteinase-9 activity in patients with acute myocardial infarction: possible role in the development of cardiac rupture.

Authors:  Kunihiko Kameda; Toshiro Matsunaga; Naoki Abe; Takayuki Fujiwara; Hiroyuki Hanada; Kozo Fukui; Ikuo Fukuda; Tomohiro Osanai; Ken Okumura
Journal:  Circ J       Date:  2006-06       Impact factor: 2.993

2.  Hospital outcome of moderate to severe pericardial effusion complicating ST-elevation acute myocardial infarction.

Authors:  Jaume Figueras; José A Barrabés; Vicens Serra; Josefa Cortadellas; Rosa-Maria Lidón; Alvaro Carrizo; David Garcia-Dorado
Journal:  Circulation       Date:  2010-10-25       Impact factor: 29.690

3.  Changes in hospital mortality rates in 425 patients with acute ST-elevation myocardial infarction and cardiac rupture over a 30-year period.

Authors:  Jaume Figueras; Oscar Alcalde; José A Barrabés; Vicens Serra; Joan Alguersuari; Josefa Cortadellas; Rosa-Maria Lidón
Journal:  Circulation       Date:  2008-12-08       Impact factor: 29.690

4.  Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI).

Authors:  John K French; Anne S Hellkamp; Paul W Armstrong; Eric Cohen; Neil S Kleiman; Christopher M O'Connor; David R Holmes; Judith S Hochman; Christopher B Granger; Kenneth W Mahaffey
Journal:  Am J Cardiol       Date:  2010-01-01       Impact factor: 2.778

5.  Effect of thrombolytic therapy on the risk of cardiac rupture and mortality in older patients with first acute myocardial infarction.

Authors:  Héctor Bueno; Manuel Martínez-Sellés; Esther Pérez-David; Ramón López-Palop
Journal:  Eur Heart J       Date:  2005-04-26       Impact factor: 29.983

6.  A risk score to predict bleeding in patients with acute coronary syndromes.

Authors:  Roxana Mehran; Stuart J Pocock; Eugenia Nikolsky; Tim Clayton; George D Dangas; Ajay J Kirtane; Helen Parise; Martin Fahy; Steven V Manoukian; Frederick Feit; Magnus E Ohman; Bernard Witzenbichler; Giulio Guagliumi; Alexandra J Lansky; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2010-06-08       Impact factor: 24.094

7.  Cardiac rupture after intravenous t-PA administration in acute ischemic stroke.

Authors:  Amar Dhand; Kazuma Nakagawa; Seema Nagpal; Jeffrey M Gelfand; Anthony S Kim; Wade S Smith; Tarik Tihan
Journal:  Neurocrit Care       Date:  2010-10       Impact factor: 3.210

Review 8.  Cardiac rupture after myocardial infarction: new insights from murine models.

Authors:  David C Sane; Willis Scott Mozingo; Richard C Becker
Journal:  Cardiol Rev       Date:  2009 Nov-Dec       Impact factor: 2.644

9.  Surgical treatment of postinfarction left ventricular free wall rupture.

Authors:  Sulieman Haddadin; Aldo D Milano; Giuseppe Faggian; Mohammed Morjan; Fabio Patelli; Giorgio Golia; Pierluigi Franchi; Alessandro Mazzucco
Journal:  J Card Surg       Date:  2009 Nov-Dec       Impact factor: 1.620

10.  Cardiac rupture complicating acute myocardial infarction in the direct percutaneous coronary intervention reperfusion era.

Authors:  Hon-Kan Yip; Chiung-Jen Wu; Hsueh-Wen Chang; Chao-Ping Wang; Cheng-I Cheng; Sarah Chua; Mien-Cheng Chen
Journal:  Chest       Date:  2003-08       Impact factor: 9.410

View more
  2 in total

1.  Predictive factors of cardiac rupture in patients with ST-elevation myocardial infarction.

Authors:  Geng Qian; Chen Wu; Yun-dai Chen; Chen-chen Tu; Jin-wen Wang; Yong-an Qian
Journal:  J Zhejiang Univ Sci B       Date:  2014-12       Impact factor: 3.066

2.  Comparison of the risk of left ventricular free wall rupture in Taiwanese patients with ST-elevation acute myocardial infarction undergoing different reperfusion strategies: A medical record review study.

Authors:  Rei-Yeuh Chang; Han-Lin Tsai; Ping-Gune Hsiao; Chao-Wen Tan; Chi-Pin Lee; I-Tseng Chu; Yung-Ping Chen; Cheng-Yun Chen
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.